The seed round was led by Love Ventures with participation from Concrete Ventures and industry angels.
"Having developed a unique market-leading solution for the commercial property leasing process, we felt that the size of the opportunity to expand into new sectors and geographies warranted an influx of capital. In Love Ventures, Concrete Ventures and multiple industry-leading angels, we have got passionate, smart and supportive partners who we are thrilled to welcome aboard for the next phase of our journey."
Archangels led the financing round to support the development of the company cell analysis platform.
"On behalf of our Board and employees I would like to thank our investors for their continued support of Cytomos. We now have the growth capital required to advance the development of our novel process analytical technology platform to the next phase of prototype evaluation with our strategic partners. This is an important milestone in the journey to deliver our mission to enable the development and manufacture of life saving biologic therapies"
The financing round was backed by investors including Elkstone Capital, SciFounders, and Faber.
"Our mission is to revolutionise the user experience of healthcare. We do that by building medical devices with a patient-first approach, and focusing on the needs that truly matter to patients. This funding round will allow us to complete first in patient clinical trials of our innovative Lily Device, and accelerate our path to market launch and patient impact in 2024"
The seed round was led by Stride VC and will fund product investment, research, and expansion.
"Our team is united in the belief that hiring is inefficient, outdated and unfair to candidates around the world. We have all been hiring managers and candidates, and we know the hiring process is broken. It’s difficult to track and measure, meaning there’s a lack of insight into what to improve and what to prioritise. Companies struggle to replicate their top performers and the cost of a failed hire is over $180,0001."
The seed round was led by Ecovative Design to fund the opening of a new raw material production plant.
"We have just eight years to meet the UN’s Sustainable Development Goals and businesses have a crucial role to play – but they need viable and cost-effective solutions that significantly reduce the carbon footprint across their entire supply chain. We’re proud to be creating value from waste and unlocking the potential of mycelium – a resource that has been untapped to date. We’re delighted to have the support of a brilliant group of investors who have a wealth of experience in driving sustainable change and share our vision for the future of packaging solutions. The magic of mushrooms is only just being realised and we can’t wait to make it mainstream."
